video thumbnail

Nasal Spray for Virus/SARS-COV-2 Reduction

Duration: 21:28

Write A New Comment

1 Comments

...

joan.roderick@*.com

Apr 22 2021, 4:15 pm

WOW!!

Nasal Spray for Virus/SARS-COV-2 Reduction

A Canadian company has successfully run trials and tests to show that nitric oxide based nasal spray can reduce viral replication by 99.99% in 72 hours. Let’s look at this spray, the test results, and its mechanism of action for viruses.

Pre-read/watch
DrBeen’s discussion about N-AcetylCysteine
https://youtu.be/K8kKWgsGIU8

About Cysteine and Cystine
https://www.sciencedirect.com/topics/chemistry/sulfur-containing-amino-acid

saNotize nasal spray site.
https://sanotize.com/covid-19/

About NO
https://sanotize.com/why-nitric-oxide/

About neuraminidase inhibitors
https://en.wikipedia.org/wiki/Neuraminidase_inhibitor

About neuraminidase
https://en.wikipedia.org/wiki/Neuraminidase

About NO from Goodman Gillman for reference
Platelet activation and coagulation do not normally occur within an intact blood vessel. Thrombosis is prevented by several regulatory mechanisms that require healthy vascular endothelium. Nitric oxide and prostacyclin synthesized by endothelial cells inhibit platelet activation

Produced by activated helper T (TH) and natural killer (NK) cells, IFN-γ enhances the microbicidal activity of macrophages by inducing mammalian inducible nitric oxide synthase (iNOS, also called NOS2), thereby increasing their production of nitric oxide (NO) and their capacity to kill intracellular pathogens.

Brunton, Laurence; Knollman, Bjorn; Hilal-Dandan, Randa. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition (Goodman and Gilman"S the Pharmacological Basis of Therapeutics) . McGraw-Hill Education. Kindle Edition. 

Learning Objectives for Nasal Spray for SARS-COV-2 Virus Reduction

A few nasal sprays have shown efficacy in reducing viruses in the nasal epithelium. This session will review a nitric oxide-based nasal spray given authorization for SARS-COV-2 reduction in Israel and New Zealand.

 

Learning Objectives

  1. Viral load reduction percentages achieved with the nitrico oxide based nasal spray.
  2. Mechanism of action.
  3. When to use this nasal spray? For example, in a doctor's clinic.
  4. Results of the trial conducted for reducing SARS-COV-2 load in the nasopharyngeal area.
  5. In-vitro study using NO based nasal spray by the Utah State University.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharmacology

Related Videos